Genomic approaches to the pathogenesis and treatment of acute lymphoblastic leukemiasARMSTRONG, Scott A; HSIEH, James J-D; KORSMEYER, Stanley J et al.Current opinion in hematology. 2002, Vol 9, Num 4, pp 339-344, issn 1065-6251Article

A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor GrowthCHEN, David Y; LEE, Yishan; OH, Kyoung J et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 3, pp 736-746, issn 0008-5472, 11 p.Article

Design, syntheses, and evaluation of Taspase1 inhibitorsJEONG TAE LEE; CHEN, David Y; ZHIMOU YANG et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 17, pp 5086-5090, issn 0960-894X, 5 p.Article

BID, BIM, and PUMA Are Essential for Activation of the BAX- and BAK-Dependent Cell Death ProgramDECHENG REN; TU, Ho-Chou; KIM, Hyungjin et al.Science (Washington, D.C.). 2010, Vol 330, Num 6009, pp 1390-1393, issn 0036-8075, 4 p.Article

Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpointHAN LIU; TAKEDA, Shugaku; KUMAR, Rakesh et al.Nature (London). 2010, Vol 467, Num 7313, pp 343-346, issn 0028-0836, 4 p.Article